Fairvalue-Calculator Fairvalue-Calculator
EN DE

Terveystalo Oyj (TTALO) Fair Value & Analysis

Healthcare · FI · Market cap €1.0B

Price€7.55
Fair Value€13.24
Upside+75.4%
Quality95/100
Evidence: High Range €9.31 – €17.85

Analysis

Terveystalo Oyj (TTALO) currently trades at €7.55, while our model-based Fair Value estimate is €13.24 — implying the stock looks roughly 75.4% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Terveystalo Oyj provides occupational healthcare services in Finland, Sweden, and Estonia. It operates through three segments: Healthcare Services, Portfolio Businesses, and Sweden. The company offers general practice and specialist medical care, diagnostic, outpatient surgery, dental, and other adjacent services; healthcare outsourcing and staffing services; child welfare services; and oral health, social, ER, well-being, and primary healthcare and specialty care services, as well as imaging and laboratory tests. It also provides remote and digital, diagnostic and screening, therapy and rehabilitation, and occupational health; leasing of personnel, partnership solutions, and assessment of the need for care; and organizational management consulting and addiction prevention services. The company serves private individuals and families, corporate and consumer, insurance companies, and public sector customers. Terveystalo Oyj was founded in 2001 and is headquartered in Helsinki, Finland.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.